Financial Daily from THE HINDU group of publications
Tuesday, Oct 26, 2004
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate Results - Pharmaceuticals


Glenmark net doubles

Our Bureau

MUMBAI: Glenmark Pharmaceuticals Ltd has clocked a 101.11 per cent growth in net profit, at Rs 28.94 crore, for the second quarter ended September 30, 2004.

The company has registered a 51.7 per cent growth in revenue, clocking Rs 160.25 crore in the same period.

Glenmark has promoted four new products during the last quarter including Mignar (Miglitol), Carboflot (Carbonyl Iron), L-Cetridoc (Levocetrizine) and Mucaryl AX, a company communiqué said.

The company has also filed 50 additional registrations in several of its export markets and commenced the export of 40 additional products for which registrations were granted in the quarter, it added.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Reliance Q2 net rises 39 pc — Improved margins in petrochem, refining

Reliance Info trims Q2 loss to Rs 50 cr
L&T posts 14 pc rise in Q2 net — Announces special dividend of Rs 10
Indo Gulf Fertilisers' Q2 profit dips to Rs 16.19 cr
Glenmark net doubles
Tata Power Q2 net down 17 pc
Monnet Ispat net climbs; declares 25 pc interim
Ispat Ind Q2 net at Rs 77.47 crore
Nava Bharat Ferro net up
Raymond reports fall in net profit
TVS Motor Q2 net down to Rs 34 cr; to pay 70 pc interim
HCL Tech Q1 net income up 71 pc
Indal Q2 net grows 50% at Rs 47 cr
LMW Q2 net rises 44.6 pc
HDFC Q2 net up 22 pc at Rs 248 cr
Vijaya Bank Q2 net declines 26 per cent

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line